These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 35032337)

  • 1. Hair and nail manifestations of COVID-19.
    Tammaro A; Adebanjo GAR; Parisella FR; Luzi F; Scarabello A
    J Cosmet Dermatol; 2022 Apr; 21(4):1339-1346. PubMed ID: 35032337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of SARS-CoV-2 infection and its vaccines in various types of hair loss.
    Aryanian Z; Balighi K; Hatami P; Afshar ZM; Mohandesi NA
    Dermatol Ther; 2022 Jun; 35(6):e15433. PubMed ID: 35266262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of hair loss after severe acute respiratory syndrome coronavirus 2 infection: Insight into the pathophysiology with implication for better management.
    Ohyama M; Matsudo K; Fujita T
    J Dermatol; 2022 Oct; 49(10):939-947. PubMed ID: 35633047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Telogen effluvium related to post severe Sars-Cov-2 infection: Clinical aspects and our management experience.
    Rizzetto G; Diotallevi F; Campanati A; Radi G; Bianchelli T; Molinelli E; Mazzanti S; Offidani A
    Dermatol Ther; 2021 Jan; 34(1):e14547. PubMed ID: 33190397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A systematic review of acute telogen effluvium, a harrowing post-COVID-19 manifestation.
    Hussain N; Agarwala P; Iqbal K; Omar HMS; Jangid G; Patel V; Rathore SS; Kumari C; Velasquez-Botero F; López GAB; Vishwakarma Y; Nipu AP; Ahmed NK
    J Med Virol; 2022 Apr; 94(4):1391-1401. PubMed ID: 34931698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Review of the post-COVID-19 syndrome associated to acute telogen effluvium].
    Chávez-Chavira G
    Rev Med Inst Mex Seguro Soc; 2023 Jul; 61(4):496-501. PubMed ID: 37540705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COVID-19 infection is a major cause of acute telogen effluvium.
    Sharquie KE; Jabbar RI
    Ir J Med Sci; 2022 Aug; 191(4):1677-1681. PubMed ID: 34467470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19 induced telogen effluvium.
    Aksoy H; Yıldırım UM; Ergen P; Gürel MS
    Dermatol Ther; 2021 Nov; 34(6):e15175. PubMed ID: 34708909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics of hair loss after COVID-19: A systematic scoping review.
    Czech T; Sugihara S; Nishimura Y
    J Cosmet Dermatol; 2022 Sep; 21(9):3655-3662. PubMed ID: 35801366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of autologous micrografts injection from the scalp tissue in the treatment of COVID-19 associated telogen effluvium: Clinical and trichoscopic evaluation.
    Hawwam SA; Ismail M; Elhawary EE
    Dermatol Ther; 2022 Jul; 35(7):e15545. PubMed ID: 35486375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of COVID-19 on development of hair and nail disorders: a Turkish multicenter, controlled study.
    Kutlu Ö; Demircan YT; Yıldız K; Kalkan G; Demirseren DD; An İ; Oba MÇ; Emre S; Şenel E; Bilgili SG; Savaş SE; Aktürk AŞ; Türkmen D; Çakmak SK; Kulaklı S; Demirbaş A; Altunışık N; Coşansu NC; Aksoy GG; Tosun M; Kurt BÖ; Şentürk N; Şener S; Özden HK; Temiz SA; Atak MF; Süslü H; Oğuz ID; Kılıç S; Ustaoğlu E; Topal İO; Akbulut TÖ; Korkmaz İ; Kılıç A; Hızlı P; Küçük ÖS; Çaytemel C; Kara RÖ; Koska MC; Tatar K; Dikicier BS; Ağırgöl Ş; Akşan B; Karadağ AS
    Int J Dermatol; 2023 Feb; 62(2):202-211. PubMed ID: 36281828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of patients with telogen effluvium during the pandemic: May the monocytes be responsible for post COVID-19 telogen effluvium?
    Koç Yıldırım S; Erbağcı E; Demirel Öğüt N
    J Cosmet Dermatol; 2022 May; 21(5):1809-1815. PubMed ID: 35201647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hair disorders associated with post-COVID-19 infection in females: a cross-sectional study.
    Awad NEHA; Obaid ZM; Zaky MS; Elsaie ML
    Ir J Med Sci; 2024 Apr; 193(2):761-767. PubMed ID: 37704885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of telogen effluvium hair loss in COVID-19 patients and its relationship with disease severity.
    Seyfi S; Alijanpour R; Aryanian Z; Ezoji K; Mahmoudi M
    J Med Life; 2022 May; 15(5):631-634. PubMed ID: 35815081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trichotillomania: Bizzare Patern of Hair Loss at 11-Year-old Girl.
    Zímová J; Zímová P
    Acta Dermatovenerol Croat; 2016 Jun; 24(2):150-3. PubMed ID: 27477178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequential cyclic changes of hair roots revealed by dermoscopy demonstrate a progressive mechanism of diffuse alopecia areata over time.
    Zhang X; Ye Y; Zhu Z; Yang Y; Cao H; McElwee KJ; Ling Y
    Exp Dermatol; 2020 Mar; 29(3):223-230. PubMed ID: 30307062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Telogen effluvium and COVID-19: a cross-sectional study.
    Aldahish A; Vasudevan R; Salem H; Alqahtani A; AlQasim S; Alqhatani A; Al Shahrani M; Al Mohsen L; Hajla M; Calina D; Sharifi-Rad J
    Eur Rev Med Pharmacol Sci; 2023 Aug; 27(16):7823-7830. PubMed ID: 37667959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Telogen effluvium associated with COVID-19 infection.
    Olds H; Liu J; Luk K; Lim HW; Ozog D; Rambhatla PV
    Dermatol Ther; 2021 Mar; 34(2):e14761. PubMed ID: 33405302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Red LED light therapy for telogen effluvium in the course of long COVID in patients with and without androgenetic alopecia.
    Gerkowicz A; Bartosińska J; Krakowski P; Karpiński R; Krasowska D; Raczkiewicz D; Kwasny M; Krasowska D
    Ann Agric Environ Med; 2024 Jun; 31(2):239-247. PubMed ID: 38940108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SYMPTOMATOLOGY AND TREATMENT OF COVID-19 AFFECTING SKIN APPENDAGES: A NARRATIVE REVIEW BEYOND COVID-TOES.
    Wollina U; Abdelmaksoud A; Chiriac A; Brzezinski P; Temiz S
    Georgian Med News; 2022 Oct; (331):78-84. PubMed ID: 36539135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.